Cargando…
Support for a tax increase to provide unrestricted access to an Alzheimer's disease medication: a survey of the general public in Canada
BACKGROUND: Public drug insurance plans provide limited reimbursement for Alzheimer's disease (AD) medications in many jurisdictions, including Canada and the United Kingdom. This study was conducted to assess Canadians' level of support for an increase in annual personal income taxes to f...
Autores principales: | Oremus, Mark, Tarride, Jean-Eric, Clayton, Natasha, Raina, Parminder |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806272/ https://www.ncbi.nlm.nih.gov/pubmed/20040110 http://dx.doi.org/10.1186/1472-6963-9-246 |
Ejemplares similares
-
How Does the Canadian General Public Rate Moderate Alzheimer's Disease?
por: Tarride, Jean-Eric, et al.
Publicado: (2011) -
A comparison of health utility scores calculated using United Kingdom and Canadian preference weights in persons with alzheimer’s disease and their caregivers
por: Fang, Mingying, et al.
Publicado: (2016) -
Association between caregiver quality of life and the care provided to persons with Alzheimer’s disease: protocol for a systematic review
por: Hazzan, Afeez Abiola, et al.
Publicado: (2013) -
The association between caregiver well-being and care provided to persons with Alzheimer’s disease and related disorders
por: Hazzan, Afeez Abiola, et al.
Publicado: (2016) -
Metagenomics: Unrestricted access to microbial communities
por: Allan, Elaine
Publicado: (2014)